ENVALITH
株式会社エンバイオ・ホールディングス logo

EnBio Holdings, Inc

6092Standard MarketServices

株式会社エンバイオ・ホールディングス logo
EnBio Holdings, Inc6092
Reference Indicators

Market Cap

59¥100M

P/E (Forecast)

8.4x

P/B

0.6x

Dividend Yield (Forecast)

3.34%

ROE

2.9%

EV/EBITDA

5.8x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
8,9878,1209,57510,66812,630
Cost of Sales
6,5615,3557,0918,0148,942
Gross Profit
2,4262,7642,4842,6533,688
SG&A Expenses
1,1961,4071,6681,8142,069
Operating Income
1,2291,3578158391,619
Non-operating Income
145137424102183
Non-operating Expenses
176151171239203
Ordinary Income
1,1971,3431,0677021,598
Extraordinary Income
0109238
Extraordinary Losses
98110129921
Pre-tax Income
1,0991,2321,065702915
Income Taxes
392437326281663
Net Income
654812708452265
EBITDA
1,5701,7571,2531,3372,162
Gross Margin
27.0%34.0%25.9%24.9%29.2%
Operating Margin
13.7%16.7%8.5%7.9%12.8%
ROA
4.0%4.7%3.7%2.1%1.2%
ROE
11.7%12.8%9.3%5.1%2.9%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
土壌汚染対策事業6,91300.0%
ブラウンフィールド活用事業3,24800.0%
自然エネルギー事業2,46800.0%